CHEMUNG FINANCIAL CORP (CHMG) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US1640241014
CHEMUNG FINANCIAL CORP financials
| Fiscal year | 2025 |
|---|---|
| EBIT | 19.94 m USD |
| Net income | 15.10 m USD |
| Diluted EPS – continuing operations | 3.14 USD |
Full history since 1993, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CHEMUNG FINANCIAL CORP
Chemung Financial Corporation operates as a bank holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services. The company provides demand, savings, and time deposits; non-interest and interest-bearing checking accounts; and insured money market deposits. It also offers commercial and agricultural loans comprising loans to small to mid-sized businesses; commercial and residential mortgage loans; and consumer loans, including home equity lines of credit and home equity term loans, as well as automobile loans. In addition, the company provides interest rate swaps, letters of credit, employee benefit plans, insurance products, mutual fund, brokerage, and tax preparation services. Further, it offers guardian, custodian, trustee, investment, pension, estate planning, and employee benefit administrative services, as well as acts as an agent for pension, profit-sharing, and other employee benefit trusts. The company was founded in 1833 and is based in Elmira, New York.
More stocks
- Changzhou Evergreen Technology Co. Ltd. A (001324.SZ)
- Onconic Therapeutics Inc. (476060.KQ)
- IQE PLC (IQE.L)
- Jiangsu Apon Medical Technology Co Ltd Class A (300753.SZ)
- Xinjiang Chalkis Co Ltd (000972.SZ)
- First Bancorp, Inc /ME/ (FNLC)
- CITIZENS FINANCIAL SERVICES INC (CZFS)
- Surya Permata Andalan Tbk PT (NATO.JK)
- Hyundai Bioscience Co. Ltd (048410.KQ)
- BlossomHill Therapeutics, Inc. Common Stock (BLSM)
- Avalo Therapeutics, Inc. (AVTX)
- Oxiquim S.A (OXIQUIM.SN)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.